Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.9M Sell
1,962
-291
-13% -$463K 0.97% 24
2026
Q1
$2.98M Sell
2,253
-106
-4% -$145K 0.82% 29
2025
Q4
$2.52M Buy
2,359
+21
+0.9% +$21.9K 0.67% 35
2025
Q3
$2.26M Buy
2,338
+94
+4% +$73.9K 0.62% 41
2025
Q2
$1.8M Buy
2,244
+482
+27% +$346K 0.53% 50
2025
Q1
$1.17M Buy
1,762
+742
+73% +$540K 0.36% 68
2024
Q4
$707K Buy
+1,020
New +$732K 0.21% 102

Other funds holding ASML

Roberts, Glore & Co's ASML Position: Q2 2026 in Review

Roberts, Glore & Co reduced its ASML (ASML) stake by 13% in Q2 2026, selling an estimated $463K and leaving 1,962 shares worth $3.9M. The position accounts for 0.97% of the portfolio, ranked #24.

Roberts, Glore & Co first reported a position in ASML in Q4 2024 and has held it in 7 quarters since. 2,510 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Roberts, Glore & Co held 1,962 shares of ASML worth $3.9M as of Q2 2026.
  • Roberts, Glore & Co sold 291 ASML shares in Q2 2026, an estimated $463K.
  • ASML made up 0.97% of Roberts, Glore & Co's portfolio in Q2 2026, its #24 holding.
  • Roberts, Glore & Co first reported a position in ASML in Q4 2024 and has held it in 7 quarters since.
  • 2,510 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Roberts, Glore & Co's 13F filing for Q2 2026, filed 11 Aug 2026.